Magnesium lithospermate B

Drug Profile

Magnesium lithospermate B

Alternative Names: depsides salts

Latest Information Update: 02 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chinese Academy of Sciences; Kyushi University; Toyama Medical and Pharmaceutical University
  • Developer Kyushi University; Toyama Medical and Pharmaceutical University
  • Class Anticoagulants; Antihypertensives; Phytotherapies
  • Mechanism of Action Platelet aggregation inhibitors; Prostaglandin agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Angina pectoris; Hypertension

Most Recent Events

  • 08 Aug 2007 Discontinued for Hypertension in Japan (unspecified route)
  • 25 May 2005 Registered for Angina pectoris in China (Parenteral)
  • 09 Jun 1997 No-Development-Reported for Hypertension in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top